Not sure your position, but I do believe in the science and that they may indeed have the “cure in [their] pocket.” In fact, I even bought some more shares yesterday to average down to $1. My concern is not so much whether the products work well enough, but more to the tune of “How the heck are we gonna ride out to 2020 or beyond with almost no cash, expensive trials to complete, and the twins’ proven history of 100% failure to get a deal done with someone. Maybe they don’t have the cure, or maybe they don’t know how to ink a deal and raise money and get this company making itself money. I’m leaning towards the latter. I’ll be 35 in 2022, so as long as no reverse split and an eventual approval, I’ll hang on for the “ride.” Still investing but small amounts incrementally. Might as well at this point after 8 years.
News 
Market Data 
Discover 
